Holen Sie sich die Stockscreener-App
25.45
1.34%
0.3208
Schlusskurs vom Vortag:
$25.13
Offen:
$25.15
24-Stunden-Volumen:
143.99K
Relative Volume:
0.20
Marktkapitalisierung:
$1.24B
Einnahmen:
$458.69M
Nettoeinkommen (Verlust:
$11.68M
KGV:
105.96
EPS:
0.2402
Netto-Cashflow:
$14.58M
1W Leistung:
-3.32%
1M Leistung:
-6.10%
6M Leistung:
-29.44%
1J Leistung:
-40.01%
1-Tages-Spanne:
$24.72
$25.72
1-Wochen-Bereich:
$24.72
$26.90
52-Wochen-Spanne:
$19.16
$48.25
Artivion Inc Stock (AORT) Company Profile
Firmenname
Artivion Inc
Sektor
Branche
Telefon
(770) 419-3355
Adresse
1655 ROBERTS BOULEVARD N W, KENNESAW
Compare AORT vs ABT, MDT, SYK, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AORT
Artivion Inc
|
25.43 | 1.23B | 458.69M | 11.68M | 14.58M | 0.2402 |
ABT
Abbott Laboratories
|
106.29 | 182.59B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
92.60 | 118.18B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
274.80 | 106.03B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
45.45 | 65.19B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.47 | 49.99B | 6.30B | 1.07B | 1.09B | 1.8406 |
Artivion Inc Stock (AORT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-10 | Hochstufung | Ladenburg Thalmann | Neutral → Buy |
| 2025-08-13 | Herabstufung | Ladenburg Thalmann | Buy → Neutral |
| 2025-06-17 | Eingeleitet | Canaccord Genuity | Buy |
| 2024-10-23 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2022-09-27 | Bestätigt | Lake Street | Buy |
| 2022-08-08 | Eingeleitet | Lake Street | Buy |
| 2022-03-03 | Eingeleitet | Stifel | Buy |
Alle ansehen
Artivion Inc Aktie (AORT) Neueste Nachrichten
Artivion Inc (AORT) Insider Sell: SVP, Regulatory and Quality An - GuruFocus
Artivion SVP Andrew Green sells $216k in stock By Investing.com - Investing.com South Africa
Artivion SVP Andrew Green sells $216k in stock - Investing.com
Artivion (NYSE: AORT) insider logged a 44,001-share sale and now plans more trades - Stock Titan
Artivion (NYSE: AORT) officer may sell $177K in stock - Stock Titan
Artivion Inc. (AORT) Holds Steady at $26.75 as Consolidation ContinuesElliott Wave Entry - siam.in
Artivion (AORT) Bounces As AMDS Launch Narrative Keeps Fair Value In Focus - Yahoo Finance
Artivion (AORT) Quarterly Figures: The Available Earnings Metric Delivers a Miss in the Reported Period; Session Move - siam.in
Have Artivion Insiders Been Selling Stock? - Sahm
Artivion CEO James P. Mackin Sells 70,000 Shares of Common Stock at $28.955 Average Price - Kalkine Media
Artivion Inc (AORT) President & CEO James Mackin Sells 70,000 Sh - GuruFocus
Insider Selling: Artivion (NYSE:AORT) CEO Sells $2,026,500.00 in Stock - MarketBeat
Artivion (AORT) Results Review: EPS Falls Short of Its Estimate at the Close; After Results: The Stock Ends Down 0.28% in the Latest ReadingFinancial Summary - vinanet.vn
Artivion (AORT) Q2 2026 Earnings Call Transcript - AOL.com
Does Revenue Growth Amid New Losses Reshape The Bull Case For Artivion (AORT)? - simplywall.st
Why Artivion (AORT) Stock Is Trading Up Today - Yahoo Finance
Artivion (NASDAQ: AORT) executive moves to sell 70,000 shares - Stock Titan
Summit Creek Advisors LLC Takes Position in Artivion, Inc. $AORT - MarketBeat
Artivion (NYSE:AORT) Stock Price Up 5.7%Still a Buy? - MarketBeat
Canaccord raises Artivion stock price target to $40 on model update - Investing.com
Artivion CFO Lance A. Berry Sells 715 Shares to Cover RSU Tax Withholding - Kalkine Media
Artivion Inc. (AORT) Slides 2.8% to $28.32: Key Support Levels in FocusLow Vol Factor - vinanet.vn
Artivion EVP, COO, CFO & treasurer Berry sells $20,412 in stock - Investing.com Nigeria
Artivion SVP Andrew Green sells $17,586 of common stock - Investing.com
Artivion SVP Andrew Green sells $17,586 of common stock By Investing.com - Investing.com Canada
Artivion (NYSE: AORT) exec’s 616-share sale is tax-driven - Stock Titan
Artivion (AORT) Declines 1.82% to $28.61, Testing Key Support ZoneDollar Neutral Pair - vinanet.vn
Artivion (AORT) Edges Lower to $28.89 as Range-Bound Trading PersistsWyckoff Upthrust - vinanet.vn
5 Revealing Analyst Questions From Artivion’s Q2 Earnings Call - Yahoo Finance
Royal Bank of Canada Purchases 39,553 Shares of Artivion, Inc. $AORT - MarketBeat
Artivion (NYSE:AORT) Rating Lowered to Sell at Wall Street Zen - MarketBeat
ARTIVION, INC. SEC Filing (Aug 14, 2026) - Stock Titan
AORT (AORT) investor files to sell 616 shares after 44,001-share sale - Stock Titan
Artivion (AORT): Nomura entities report 6.5% beneficial stake in 13G/A - Stock Titan
AORT Q2 2026 Earnings: Loss Per Share of -$0.28 Delivers a 2,845.1% Negative SurpriseProfit Announcement - vinanet.vn
Artivion Inc (AORT) SVP and General Counsel Jean Holloway Sells 977 Shares - GuruFocus
Artivion SVP Jean Holloway sells 977 shares for $27,834 By Investing.com - Investing.com India
Jean Holloway Sells 977 Shares of Artivion (NYSE:AORT) Stock - MarketBeat
Artivion at canaccord growth conference: pipeline drives growth plan By Investing.com - Investing.com Canada
Artivion at canaccord growth conference: pipeline drives growth plan - Investing.com
Artivion SVP Jean Holloway sells 977 shares for $27,834 - Investing.com
Artivion (AORT) Is Up 5.5% After FDA AMDS Approval And Reaffirmed 2026 Revenue GuidanceWhat's Changed - simplywall.st
Artivion, Inc. (AORT) Stock Price, News, Quote & History - ca.finance.yahoo.com
Can Artivion (NYSE:AORT) Gain Ground on the NYSE Composite? - Kalkine Media
Artivion (NYSE:AORT) Stock Price Up 8.2%What's Next? - MarketBeat
Artivion, Inc. (AORT) Stock Analysis: Strong Buy Ratings Signal Potential Upside of Nearly 60% - DirectorsTalk Interviews
Artivion, Inc. (AORT) stock price, news, quote and history - Yahoo Finance UK
Artivion revenue up 11% to USD 125.8M in Q2 2026 - Medical Buyer
Artivion Inc (AORT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Finanzdaten der Artivion Inc-Aktie (AORT)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.72%
0.85%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):